Xiaowei Jin

Dorzagliatin (HMS5552), a novel dual‐acting glucokinase activator, improves glycaemic control and pancreatic β‐cell function in patients with type 2 diabetes: A 28‐day treatment study using biomarker‐guided patient selection

Xiaoxue Zhu, Dalong Zhu, Yalin Li et al. · Diabetes Obesity and Metabolism · 2018 · 61 citations

Medicine, Endocrinology, Pharmacology +17

Characterization of the strain-rate–dependent mechanical response of single cell–cell junctions

Amir Monemian Esfahani, Jordan Rosenbohm, Bahareh Tajvidi Safa et al. · Proceedings of the National Academy of Sciences · 2021 · 60 citations · Full text

Natural Sciences, Biophysics, Cell Biology +17

Liquid crystal monomers disrupt photoreceptor patterning of zebrafish larvae via thyroid hormone signaling

Jia He, Siying Ma, Kunyu Wei et al. · Environment International · 2024 · 38 citations · Full text

Veterinary Medicine, Neuroscience, Toxicology +17

Effect of renal impairment on the pharmacokinetics and safety of dorzagliatin, a novel dual‐acting glucokinase activator

Jia Miao, Ping Fu, Shuang Ren et al. · Clinical and Translational Science · 2021 · 25 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Kaempferol Promotes Transplant Tolerance by Sustaining CD4+FoxP3+ Regulatory T Cells in the Presence of Calcineurin Inhibitor

Yuqun Zeng, X.S. Liu, Sean M. Wu et al. · American Journal of Transplantation · 2015 · 19 citations · Full text

Medicine, Immunology, Pharmacology +14